Ozempic: The Swiss Army Knife of Weight Loss Drugs
Photo by Simon Schwyter on Unsplash
One in ten Americans is now casually poking themselves with GLP-1 drugs like Ozempic, Wegovy, or Mounjaro — not just to ditch carbs, but to fight heart disease, dementia, and even addiction. Experts warn, 'We are entering the Ozempic era,' but also caution about unknown 20- or 30-year effects. While some claim these meds zap junk food cravings—hello, baked beans obsession!—others wonder if suppressing desire might turn us into 'emotionless robots.' GLP-1s are the pharmaceutical equivalent of a Gila monster's secret weapon, solving everything but how to explain to your hipster barista why you're craving tomatoes over triple lattes.
Share the Story
(1 of 3)
Swipe to navigate
Source: Vox | Published: 7/28/2025 | Author: Dylan Scott
More Articles in Health
Grandfather Gifts $1,500 with Guest Star Role for Financial Advisor
Businessinsider
TCL and Hisense Finally Throw Shade at Sony, LG, Samsung’s Premium TV Party
Theverge
Kennedy’s Protein-Heavy Food Pyramid: Eat More Meat, But Not Saturated Fat, Or Something
Axios
Parents Swap 'Because I Said So' For 'Oops, You Bought Too Much Junk'
Businessinsider
America Celebrates Lower Gun Deaths While Puffing More Vape Clouds
Axios
Trump's Vaccine Makeover: Fewer Shots, More Trust, Same Measles Risks
Axios
Woman’s Epic Fight: Type 1 Diabetes vs. Ancient Mexican Ruins Timer
Businessinsider
29-Year-Old's Stroke Upends Career With Zero Paid Sick Leave, Still Runs Meetings
Businessinsider